Sugi Predict

Sugi Predict / Targets / CDS2

CDS2

Phosphatidate cytidylyltransferase 2 · O95674 · CDS2 on Sugi Atlas →

0 patent compounds predicted against CDS2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CDS2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
NEO100 and High-Grade Meningioma PHASE2RECRUITING
Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC PHASE2COMPLETED
Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides PHASE1COMPLETED
Tolerability of Enteral NAC in Infants PHASE1NOT_YET_RECRUITING
Impact of Seasonal Malaria Chemoprevention on Immunity Against Malaria Among Children in Northern Benin nanCOMPLETED
Genetics of Primary Ciliary Dyskinesia nanCOMPLETED
Duality of Lipids: the Athlete's Paradox nanCOMPLETED
Development of Biomarker for Development of Non-Alcoholic Steatohepatitis (NASH) in Children nanWITHDRAWN
Composition & Function of Sarcoplasmic Reticulum in Persons With the Metabolic Syndrome nanCOMPLETED
Effect of Sulfur Amino Acid Depletion and Acetaminophen on Plasma Glutatione nanCOMPLETED
Diagnosis of Primary Ciliary Dyskinesia nanCOMPLETED
Effect of Omega-3 Fatty Acids Supplementation on Hypertriglyceridemia in Pediatric Patients With Obesity. nanCOMPLETED
Lipidomic and Multi-Omics Profiling of Fatty Liver Disease in People With and Without HIV nanNOT_YET_RECRUITING
PCD New Gene Discovery nanCOMPLETED
Screening of Healthy Adults for Genetic Variations That Control Fatty Acid Processing nanCOMPLETED
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease nanRECRUITING
Epidemiology of Atherosclerosis nanCOMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease. nanUNKNOWN
Identification of a New Gene Involved in Hereditary Lipodystrophy nanCOMPLETED
Artificial Intelligence for the Prioritization of Genetic Background in Brugada Syndrome nanCOMPLETED
Plant-based Diets and Body Weight and Selected Metabolic Parameters Management in Obese Patients. nanCOMPLETED
Human Requirements for the Nutrient Choline nanCOMPLETED
Molecular Markers of Human Sperm Function nanWITHDRAWN
Thermogenic Silencer Regulatory Factors in Humans nanACTIVE_NOT_RECRUITING
CIQTP Prolongation : Role and Mechanism in Sudden Cardiac Death nanCOMPLETED
Markers and Mechanisms of Macrovascular Disease in IDDM nanCOMPLETED
Celiac Disease Genomic Environmental Microbiome and Metabolomic Study nanRECRUITING
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. nanUNKNOWN
Egg Intake, Metabolic Outcomes and Choline Levels nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a CDS2 binder may also engage these)

ProteinNameSimilarity
Q99L43 — 1.000 Q99L43 →
Q91XU8 — 1.000 Q91XU8 →
A0JNC1 — 1.000 A0JNC1 →
Q92903 — 0.991 Q92903 →
O35052 — 0.990 O35052 →
P98191 — 0.990 P98191 →
Q803C9 — 0.976 Q803C9 →
Q0JR55 — 0.974 Q0JR55 →
Q6AXM5 — 0.968 Q6AXM5 →
B1H3H9 — 0.968 B1H3H9 →
Q8BGS7 — 0.968 Q8BGS7 →
Q5ZKD1 — 0.967 Q5ZKD1 →
CEPT1 Choline/ethanolaminephosphotransferase 1 0.967 landscape →
Q7ZYQ3 — 0.967 Q7ZYQ3 →
F4HXY7 — 0.966 F4HXY7 →
Q28H54 — 0.966 Q28H54 →
Q6I628 — 0.965 Q6I628 →
Q9QZ71 — 0.965 Q9QZ71 →
Q8CIF6 — 0.963 Q8CIF6 →
Q9TU72 — 0.962 Q9TU72 →
PTDSS1 Phosphatidylserine synthase 1 0.962 landscape →
Q5PQL5 — 0.962 Q5PQL5 →
D3ZEH5 — 0.962 D3ZEH5 →
Q99LH2 — 0.961 Q99LH2 →
Q0VCK9 — 0.961 Q0VCK9 →
Q6DD44 — 0.960 Q6DD44 →
Q9Z0U0 — 0.960 Q9Z0U0 →
Q00576 — 0.960 Q00576 →
Q28CY9 — 0.960 Q28CY9 →
Q5R9K4 — 0.960 Q5R9K4 →